OCT 13, 2019 8:43 AM PDT

New diagnostic tool for thyroid cancer

Thyroid cancer diagnoses have risen in the last thirty years from 6 per 100,000 to more than 14 per 100,000. That’s according to the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI), which also reports that in 2016, 822,242 people in the US had thyroid cancer. However, new research published in PNAS provides hope in light of these grim numbers.

The diagnostic process for thyroid cancer involves taking a biopsy using a fine needle aspiration (FNA); however, because FNA biopsies are inconclusive 1 out of 5 times at identifying cancer, doctors may often recommend surgery to remove part or all of the thyroid to play it safe. The problem with this is that those patients who receive surgery on their thyroids are required to take hormone replacement therapy for the entirety of their lives to be able to regulate metabolism, heart rate, body temperature, and blood pressure.

"If we could prevent people from having surgery they don't need and enable them to have a more precise diagnosis," says co-senior author of the study Livia S. Eberlin, Ph.D., assistant professor of chemistry and diagnostic medicine at The University of Texas at Austin, "we can improve treatment for patients and lower costs for the healthcare system."

The study details how the Eberlin and fellow researchers used mass spectrometry imaging to develop a molecular fingerprint for thyroid cancer based on the molecular profiles from tissues of 178 people with or without thyroid cancer.

Using this new molecular fingerprint proved to be successful in cutting the number of false-positive results from FNA procedures. As compared to the current FNA procedure, the new fingerprint test produced false-positive results in only 1 in 10 cases approximately. To put that into clearer human numbers, this could keep 17 people from undergoing unnecessary surgery.

With this new FNA development, patients would receive fewer unnecessary surgeries. Photo: Pixabay

"With this next-generation test," says co-senior study author Dr. James W. Suliburk, "we can provide thyroid cancer diagnoses faster and with more precision than current techniques — this will be the new state-of-the-art. We are able to do this analysis directly on the FNA sample and much more rapidly than the current process, which could take between 3 and 30 days." The researchers plan to continue their work with a 2-year trial to validate the FNA findings of roughly 1,000 people in the US, Brazil, and Australia.

Sources: PNAS, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 12, 2021
Cell & Molecular Biology
Hyperactive Mitochondria Can Fuel Brain Tumors
JAN 12, 2021
Hyperactive Mitochondria Can Fuel Brain Tumors
The most common and deadly form of brain cancer is known as glioblastoma; the median survival time for patients is only ...
JAN 14, 2021
Microbiology
Decontaminating the Cancer Microbiome
JAN 14, 2021
Decontaminating the Cancer Microbiome
Valid scientific conclusions require a solid foundation of good data that comes from reliable techniques. Studies that i ...
JAN 17, 2021
Cancer
Analyzing the role of our circadian clocks in prostate cancer
JAN 17, 2021
Analyzing the role of our circadian clocks in prostate cancer
Research published recently in Nature Communications looks into the role that circadian rhythms play on prostate cancer ...
FEB 16, 2021
Cancer
Fecal transplants help melanoma patients
FEB 16, 2021
Fecal transplants help melanoma patients
Introducing new microorganisms to the gut microbiome can improve patients’ response to immunotherapy, suggests res ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
APR 05, 2021
Cannabis Sciences
Can Smoking Cannabis Cause Lung Cancer?
APR 05, 2021
Can Smoking Cannabis Cause Lung Cancer?
So far, there is no firm consensus on whether smoking cannabis can cause lung cancer. As cannabis smoke contains many si ...
Loading Comments...